Obesity drug delivery test: which shot works best?
NCT ID NCT07313761
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This early-stage study tests how two different injection forms of the drug maridebart cafraglutide are processed by the body in 349 adults with overweight or obesity. Participants receive a single dose, and researchers measure drug levels and side effects. The goal is to compare the two delivery methods, not to treat the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials
Anaheim, California, 92801-2658, United States
-
CenExel Collaborative Neuroscience Research, LLC Los Alamitos
Los Alamitos, California, 90720, United States
-
Clinical Pharmacology Of Miami, LLC
Miami, Florida, 33172-3161, United States
-
Ohio Clinical Trials, Inc.
Columbus, Ohio, 43212, United States
Conditions
Explore the condition pages connected to this study.